Analyst Price Targets — ITGR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 23, 2026 2:40 pm | — | Raymond James | $101.00 | $84.95 | TheFly | Integer price target raised to $101 from $95 at Raymond James |
| December 18, 2025 2:11 pm | Richard Newitter | Truist Financial | $95.00 | $80.60 | TheFly | Integer price target raised to $95 from $86 at Truist |
| November 24, 2025 1:41 pm | — | Truist Financial | $86.00 | $69.61 | TheFly | Integer price target lowered to $86 from $88 at Truist |
| October 24, 2025 1:19 pm | — | Truist Financial | $88.00 | $73.89 | TheFly | Integer price target lowered to $88 from $121 at Truist |
| October 24, 2025 12:35 pm | Matt O'Brien | Piper Sandler | $82.00 | $73.89 | StreetInsider | Integer Holding (ITGR) PT Lowered at Piper Sandler as 'Soft 2026 Sales Outlook Steals Investor Focus' |
| October 24, 2025 12:27 pm | — | Raymond James | $95.00 | $73.89 | TheFly | Integer price target lowered to $95 from $143 at Raymond James |
| October 21, 2025 10:42 am | Brett Fishbin | KeyBanc | $133.00 | $107.37 | TheFly | Integer price target lowered to $133 from $145 at KeyBanc |
| October 15, 2025 12:36 pm | — | Truist Financial | $121.00 | $104.27 | TheFly | Integer price target lowered to $121 from $137 at Truist |
| April 25, 2025 3:58 pm | Richard Newitter | Truist Financial | $150.00 | $121.49 | TheFly | Integer price target raised to $150 from $140 at Truist |
| December 11, 2024 1:07 pm | Richard Newitter | Truist Financial | $163.00 | $140.62 | TheFly | Integer price target raised to $163 from $147 at Truist |
Latest News for ITGR
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE AN INTEGER HOLDINGS CORPORATION (ITGR) SHAREHOLDER, CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE.…
PHILADELPHIA, March 02, 2026 (GLOBE NEWSWIRE) -- Corcept Therapeutics, Inc. (NASDAQ: CORT): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On October 23, 2025, before the market opened, Integer reduced its full-year 2025 sales…
PLANO, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that members of its executive leadership team will participate in the following investor conferences in March:
Irenic Capital Management initiated a new position by purchasing 1,263,663 shares of Integer Holdings in the fourth quarter. The quarter-end position value increased by $99.11 million, reflecting both the new stake and stock price movement.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ITGR.
U.S. House Trading
No House trades found for ITGR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.